Device / Technology News

RSS

DSG's eCaseLink EDC chosen for Ariosa's Non-Invasive Chromosomal Examination of Trisomy study

Ariosa Diagnostics, a molecular diagnostics company focused on prenatal testing, has chosen to use DSG's eCaseLink EDC (electronic data capture) system for the NEXT (Non-Invasive Chromosomal Examination of Trisomy) study.

23 Apr 2012

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

Abbott and St. Jude Medical today announced Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.

23 Apr 2012

New titanium vertebral body replacement device from ulrich medical

ulrich medical USA, Inc., today announced the release of the Omni VBR Implant System, a new titanium vertebral body replacement device that is intended for use in the thoracic and lumbar spine (T1-L5) to replace a collapsed, damaged or unstable vertebral body due to tumor or trauma.

23 Apr 2012

Enrollment complete in REPRISE I clinical trial for Lotus Aortic Valve System

Boston Scientific Corporation announces that it has completed enrollment in the REPRISE I clinical trial, which is designed to evaluate the acute safety of the Lotus Aortic Valve System, the first transcatheter aortic valve replacement (TAVR) device of its kind for patients with severe aortic valve stenosis that is both fully repositionable and retrievable prior to release.

23 Apr 2012

Ahram Biosystems launches cost-effective, high-performance portable PCR system

Ahram Biosystems, Inc., a leading innovator of new life science tools, today announced the launch of Palm PCR F1-12, the economy model of its innovative portable PCR system. The F1-12 system is a cost-effective, high-performance portable PCR system, delivering PCR amplification with high speed and sensitivity in a fully portable format.

23 Apr 2012

Nano-devices cross blood-brain barrier to deliver drug to treat cerebral palsy

A team of scientists from Johns Hopkins and elsewhere have developed nano-devices that successfully cross the brain-blood barrier and deliver a drug that tames brain-damaging inflammation in rabbits with cerebral palsy.

23 Apr 2012

FDA clears Smiths Medical's ViaValve Safety I.V. Catheter

Smiths Medical, a leading global medical device manufacturer, today announced that its ViaValve Safety I.V. Catheter has been cleared by the U.S. Food and Drug Administration (FDA) and can be marketed in the United States.

23 Apr 2012

Enrollment complete for In-tunnel SeptRx European PFO Trial in Europe

SeptRx, an emerging medical device company that has developed the SeptRx Intrapocket PFO Occluder (IPO), reported today that it has completed enrollment for its "InterSEPT" (In-tunnel SeptRx European PFO Trial) clinical trial in Europe, and has entered into a partnership with CoRRect Medical GmbH for commercial distribution in Germany and Switzerland of the SeptRx IPO.

23 Apr 2012

ActiViews CT-Guide Needle Guidance System for liver interventions receives FDA 510(k) clearance

ActiViews, Inc, a company pioneering the development of simple, accurate, and cost-effective surgical navigation solutions, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its flagship product, CT-Guide Needle Guidance System, for liver interventions.

23 Apr 2012

IntegenX to accelerate commercialization of human DNA identification system with SV acquisition

IntegenX Inc., a privately held company that is a leader in the emerging field of rapid human DNA identification, today announced that it has acquired SV Corp, a wholly owned subsidiary of GE Healthcare Bio-Sciences. IntegenX will leverage SV Corp's products and intellectual property assets to expand its consumables offering and to accelerate the commercialization of its RapidHIT 200 Human DNA Identification System.

23 Apr 2012

Champ Medics to market ETView's VivaSight airway management platform in Taiwan

ETView Medical, Ltd. announced today that it has entered into a distribution agreement with Champ Medics Co., Ltd..

23 Apr 2012

OncoSec reports positive interim data from ElectroChemotherapy Phase IV head and neck cancer study

OncoSec Medical Inc., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, today announced positive interim analysis of data from 81 subjects in a Phase IV study of primary and locally recurrent squamous cell carcinoma of the head and neck (HNSCC) treated with OMS ElectroChemotherapy in Europe.

23 Apr 2012

MEDMIX develops new biomaterial delivery system

MEDMIX Systems has developed a delivery system for the use with standard single syringes to handle multi-component biomaterials such as tissue-adhesives, fibrin-glues for tissue sealing and materials for wound treatment, as well as stem-cell or PRP preparation.

23 Apr 2012

RaySearch receives order for its RayStation treatment planning system from HUMC

RaySearch Laboratories has received an order for its RayStation treatment planning system from Hallym University Medical Center in Seoul, South Korea.

23 Apr 2012

Data from 2 new studies on RHD presented at World Congress of Cardiology

Widespread screening of children in poorer countries is now being studied and is resulting in the diagnosis of rheumatic heart disease (RHD) in patients that would likely have gone undetected under normal circumstances, according to two new studies carried out in Fiji and Uganda presented today at the World Congress of Cardiology.

23 Apr 2012

Study describes new method to manufacture nerve guidance conduits

Engineers at the University of Sheffield have developed a method of assisting nerves damaged by traumatic accidents to repair naturally, which could improve the chances of restoring sensation and movement in injured limbs.

23 Apr 2012

Health Discovery launches MelApp for melanoma risk assessment

Health Discovery Corporation, the molecular diagnostics company that launched MelApp, the first SVM-based image analysis iPhone app for melanoma risk assessment is featured in this month's Men's Health Magazine.

21 Apr 2012

VeriStrat test may be useful for NSCLC clinical decision-making

Results from the combined analysis of two European Phase II trials were presented today at the 3rd European Lung Cancer Conference in Geneva, Switzerland. The VeriStrat retrospective analysis was performed on serum samples from advanced non-squamous non-small cell lung cancer (NSCLC) patients treated with the combination therapy bevacizumab plus erlotinib.

21 Apr 2012

MTR can prevent cell death after traumatic brain injury

Wake Forest Baptist Medical Center researchers seeking a successful treatment for traumatic brain injury have found that the size and extent of damaged tissue can be reduced by using a new device to prevent cell death.

21 Apr 2012

GSMA-mHA Mobile Health Summit to take place in Cape Town, South Africa

The GSMA-mHA Mobile Health Summit will be hosted in Cape Town, South Africa on 29th May – 1st June 2012. Taking advantage of the global reach of the GSMA and mHealth Alliance, this year's summit will demonstrate the commercial scale and sustainability of mobile health initiatives.

21 Apr 2012